AMOEBA (EPA:ALMIB) | Finanzwire

Basculer en Français

10372	Companies
216173	Keywords
145882	Articles
114461	Press releases

Home
Companies
AMOEBA

PRESS RELEASE

published on 08/28/2024 at 17:45, 1 year 8 months ago

AMOEBA prepares for the commercial launch of the AXPERA Product Line in the USA with approval expected by 2025
Amoéba's biofungicide products receive US EPA's admissibility confirmation for registration dossier, accelerating industrial and commercial development. Application for market authorization has been submitted. Collaboration with Dunham Trimmer in progress

AMOEBA Collaboration Market Authorization Biofungicide US EPA
BRIEF

published on 07/02/2024 at 08:35, 1 year 10 months ago

AMOEBA: A NEW LEGAL STRUCTURE TO MAXIMISE COMMERCIAL ACTIVITIES

AMOEBA Biocontrol Cosmetics Legal Reorganisation Subsidiary
REGULATED PRESS RELEASE

published on 07/02/2024 at 08:30, 1 year 10 months ago

AMOEBA: A NEW LEGAL STRUCTURE TO MAXIMISE COMMERCIAL ACTIVITIES
Amoéba announces a reorganisation to enhance commercial activities in biocontrol and cosmetics sectors, aiming to create value for shareholders. New legal structure to optimize resources and facilitate partnerships

AMOEBA Biocontrol Cosmetics Legal Structure Commercial Activities
BRIEF

published on 06/21/2024 at 13:41, 1 year 10 months ago

Edison Issues Report on Amoéba (ALMIB)

AMOEBA Financial Report Edison Investment Research ALMIB
PRESS RELEASE

published on 06/21/2024 at 13:36, 1 year 10 months ago

Edison issues report on Amoéba (ALMIB)
Edison Investment Research Limited issues report on Amoéba (ALMIB) available for download. Not a solicitation to buy or sell securities

AMOEBA Edison Investment Research Limited Financial Analysis Report ALMIB
BRIEF

published on 06/10/2024 at 17:50, 1 year 10 months ago

AMOÉBA Confirms Development Potential in Cosmetics Sector

AMOEBA Clinical Study Cosmetics Skincare INCI List
REGULATED PRESS RELEASE

published on 06/10/2024 at 17:45, 1 year 10 months ago

CONFIRMATION OF THE DEVELOPMENT POTENTIAL OF AMOEBA IN COSMETICS
Amoéba's clinical study confirms the development potential of its cosmetic ingredient for skincare products. Management to present strategy at annual conference in Paris

AMOEBA Clinical Study Cosmetics Paris Conference Skincare Products
BRIEF

published on 05/23/2024 at 18:05, 1 year 11 months ago

AMOEBA: Ordinary and Extraordinary General Meeting Scheduled for June 27, 2024

AMOEBA Shareholders General Meeting Electronic Voting June 2024
REGULATED PRESS RELEASE

published on 05/23/2024 at 18:00, 1 year 11 months ago

AMOEBA: ORDINARY AND EXTRAORDINARY GENERAL MEETING OF 27 JUNE 2024 - Availability of preliminary documents
Amoéba announces Ordinary and Extraordinary General Meeting on June 27, 2024, in Chassieu. Shareholders can access preliminary documents online. Electronic voting available

AMOEBA Shareholders General Meeting Electronic Voting Preliminary Documents
BRIEF

published on 05/06/2024 at 17:50, 2 years ago

AMOEBA: Declaration of the total number of voting rights and the number of shares making up the capital as of April 30, 2024

AMOEBA Voting Rights Capital Financial Markets Authority April 30, 2024

Accesswire

Published on 05/09/2026 at 01:55, 1 day 5 hours ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 1 day 5 hours ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 1 day 5 hours ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 6 hours ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 1 day 7 hours ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 05/09/2026 at 19:05, 11 hours 53 minutes ago

LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 10 hours ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 11 hours ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 11 hours ago

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/08/2026 at 18:29, 1 day 12 hours ago

Designated Person Notification

Les Echos

Published on 05/07/2026 at 19:15, 2 days 11 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:06, 2 days 11 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 18:17, 2 days 12 hours ago

DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027
Published on 05/07/2026 at 18:12, 2 days 12 hours ago

LNA SANTE : Q1 2026
Published on 05/07/2026 at 17:45, 2 days 13 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE